126 related articles for article (PubMed ID: 36657027)
1. PPAR δ Agonism Ameliorates Renal Fibrosis in an Alport Syndrome Mouse Model.
Omachi K; O'Carroll C; Miner JH
Kidney360; 2023 Mar; 4(3):341-348. PubMed ID: 36657027
[TBL] [Abstract][Full Text] [Related]
2. A Neutralizing IL-11 Antibody Improves Renal Function and Increases Lifespan in a Mouse Model of Alport Syndrome.
Widjaja AA; Shekeran SG; Adami E; Ting JGW; Tan J; Viswanathan S; Lim SY; Tan PH; Hübner N; Coffman T; Cook SA
J Am Soc Nephrol; 2022 Apr; 33(4):718-730. PubMed ID: 35140116
[TBL] [Abstract][Full Text] [Related]
3. Preemptive ramipril therapy delays renal failure and reduces renal fibrosis in COL4A3-knockout mice with Alport syndrome.
Gross O; Beirowski B; Koepke ML; Kuck J; Reiner M; Addicks K; Smyth N; Schulze-Lohoff E; Weber M
Kidney Int; 2003 Feb; 63(2):438-46. PubMed ID: 12631109
[TBL] [Abstract][Full Text] [Related]
4. Anti-microRNA-21 Therapy on Top of ACE Inhibition Delays Renal Failure in Alport Syndrome Mouse Models.
Rubel D; Boulanger J; Craciun F; Xu EY; Zhang Y; Phillips L; Callahan M; Weber W; Song W; Ngai N; Bukanov NO; Shi X; Hariri A; Husson H; Ibraghimov-Beskrovnaya O; Liu S; Gross O
Cells; 2022 Feb; 11(4):. PubMed ID: 35203245
[No Abstract] [Full Text] [Related]
5. Murine recombinant angiotensin-converting enzyme 2 attenuates kidney injury in experimental Alport syndrome.
Bae EH; Fang F; Williams VR; Konvalinka A; Zhou X; Patel VB; Song X; John R; Oudit GY; Pei Y; Scholey JW
Kidney Int; 2017 Jun; 91(6):1347-1361. PubMed ID: 28249676
[TBL] [Abstract][Full Text] [Related]
6. Metformin ameliorates the severity of experimental Alport syndrome.
Omachi K; Kaseda S; Yokota T; Kamura M; Teramoto K; Kuwazuru J; Kojima H; Nohara H; Koyama K; Ohtsuki S; Misumi S; Takeo T; Nakagata N; Li JD; Shuto T; Suico MA; Miner JH; Kai H
Sci Rep; 2021 Mar; 11(1):7053. PubMed ID: 33782421
[TBL] [Abstract][Full Text] [Related]
7. Dysregulated Expression of microRNA-21 and Disease-Related Genes in Human Patients and in a Mouse Model of Alport Syndrome.
Guo J; Song W; Boulanger J; Xu EY; Wang F; Zhang Y; He Q; Wang S; Yang L; Pryce C; Phillips L; MacKenna D; Leberer E; Ibraghimov-Beskrovnaya O; Ding J; Liu S
Hum Gene Ther; 2019 Jul; 30(7):865-881. PubMed ID: 30808234
[TBL] [Abstract][Full Text] [Related]
8. Alphav beta6 integrin regulates renal fibrosis and inflammation in Alport mouse.
Hahm K; Lukashev ME; Luo Y; Yang WJ; Dolinski BM; Weinreb PH; Simon KJ; Chun Wang L; Leone DR; Lobb RR; McCrann DJ; Allaire NE; Horan GS; Fogo A; Kalluri R; Shield CF; Sheppard D; Gardner HA; Violette SM
Am J Pathol; 2007 Jan; 170(1):110-25. PubMed ID: 17200187
[TBL] [Abstract][Full Text] [Related]
9. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport Syndrome Research Collaborative.
Kashtan CE; Ding J; Gregory M; Gross O; Heidet L; Knebelmann B; Rheault M; Licht C;
Pediatr Nephrol; 2013 Jan; 28(1):5-11. PubMed ID: 22461141
[TBL] [Abstract][Full Text] [Related]
10. Progression of Alport Kidney Disease in Col4a3 Knock Out Mice Is Independent of Sex or Macrophage Depletion by Clodronate Treatment.
Kim M; Piaia A; Shenoy N; Kagan D; Gapp B; Kueng B; Weber D; Dietrich W; Ksiazek I
PLoS One; 2015; 10(11):e0141231. PubMed ID: 26555339
[TBL] [Abstract][Full Text] [Related]
11. Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.
Omachi K; Miyakita R; Fukuda R; Kai Y; Suico MA; Yokota T; Kamura M; Shuto T; Kai H
Clin Exp Nephrol; 2017 Dec; 21(6):952-960. PubMed ID: 28176019
[TBL] [Abstract][Full Text] [Related]
12. The activin receptor is stimulated in the skeleton, vasculature, heart, and kidney during chronic kidney disease.
Williams MJ; Sugatani T; Agapova OA; Fang Y; Gaut JP; Faugere MC; Malluche HH; Hruska KA
Kidney Int; 2018 Jan; 93(1):147-158. PubMed ID: 28843411
[TBL] [Abstract][Full Text] [Related]
13. CG200745, a Novel HDAC Inhibitor, Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome.
Suh SH; Choi HS; Kim CS; Kim IJ; Cha H; Cho JM; Ma SK; Kim SW; Bae EH
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098220
[TBL] [Abstract][Full Text] [Related]
14. Nephroprotective effect of the HMG-CoA-reductase inhibitor cerivastatin in a mouse model of progressive renal fibrosis in Alport syndrome.
Koepke ML; Weber M; Schulze-Lohoff E; Beirowski B; Segerer S; Gross O
Nephrol Dial Transplant; 2007 Apr; 22(4):1062-9. PubMed ID: 17287218
[TBL] [Abstract][Full Text] [Related]
15. Olmesartan Attenuates Kidney Fibrosis in a Murine Model of Alport Syndrome by Suppressing Tubular Expression of TGFβ.
Suh SH; Choi HS; Kim CS; Kim IJ; Ma SK; Scholey JW; Kim SW; Bae EH
Int J Mol Sci; 2019 Aug; 20(15):. PubMed ID: 31390839
[TBL] [Abstract][Full Text] [Related]
16. Alport Syndrome in Women and Girls.
Savige J; Colville D; Rheault M; Gear S; Lennon R; Lagas S; Finlay M; Flinter F
Clin J Am Soc Nephrol; 2016 Sep; 11(9):1713-1720. PubMed ID: 27287265
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin deficiency ameliorates Alport pathology by preventing tubular metabolic deficits.
Ding W; Yousefi K; Goncalves S; Goldstein BJ; Sabater AL; Kloosterboer A; Ritter P; Lambert G; Mendez AJ; Shehadeh LA
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563333
[TBL] [Abstract][Full Text] [Related]
18. Collagen receptors integrin alpha2beta1 and discoidin domain receptor 1 regulate maturation of the glomerular basement membrane and loss of integrin alpha2beta1 delays kidney fibrosis in COL4A3 knockout mice.
Rubel D; Frese J; Martin M; Leibnitz A; Girgert R; Miosge N; Eckes B; Müller GA; Gross O
Matrix Biol; 2014 Feb; 34():13-21. PubMed ID: 24480069
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidase like-2 contributes to renal fibrosis in Col4α3/Alport mice.
Cosgrove D; Dufek B; Meehan DT; Delimont D; Hartnett M; Samuelson G; Gratton MA; Phillips G; MacKenna DA; Bain G
Kidney Int; 2018 Aug; 94(2):303-314. PubMed ID: 29759420
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model.
Chen D; Jefferson B; Harvey SJ; Zheng K; Gartley CJ; Jacobs RM; Thorner PS
J Am Soc Nephrol; 2003 Mar; 14(3):690-8. PubMed ID: 12595505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
